Vardenafil (Levitra/Staxyn) Efficacy Reports From Real Users

At a glance
- Drug class / PDE5 inhibitor, FDA-approved 2003
- Standard dose range / 5 mg, 10 mg, or 20 mg taken 25 to 60 minutes before sexual activity
- Onset reported by users / 15 to 30 minutes for most; some report effects within 10 minutes
- Duration of action / 4 to 5 hours on average, with some users reporting up to 8 hours
- Drugs.com average rating / 8.2 out of 10 across 100+ reviews for erectile dysfunction
- Key trial success rate / 80% of attempts resulted in successful intercourse at 20 mg (Porst 2003)
- Staxyn (ODT form) / 10 mg orally disintegrating tablet, no water needed
- Common side effects / headache, flushing, nasal congestion, dyspepsia
- Food interaction / high-fat meals may delay onset by up to 1 hour
- Cost range / generic vardenafil available since 2018; brand Levitra discontinued in some markets
What the Clinical Trials Actually Showed
Vardenafil earned FDA approval based on a series of randomized, placebo-controlled studies that enrolled thousands of men with erectile dysfunction of varying severity and origin. The data set a benchmark that user reports still echo two decades later.
The Porst et al. fixed-dose study (2003) randomized 805 men across four arms: placebo, 5 mg, 10 mg, and 20 mg vardenafil. At the 20 mg dose, the per-patient intercourse success rate hit 80%, compared with 30% for placebo. The 10 mg group reached 75%. These were men with ED lasting an average of five years, and roughly one-third had diabetes.
A separate 12-week trial published in Diabetes Care focused exclusively on men with type 2 diabetes. Vardenafil 20 mg improved the erectile function domain score of the International Index of Erectile Function (IIEF) by 6.6 points over placebo (P<0.001). That is a clinically meaningful difference. The diabetic subgroup matters because ED in diabetes tends to be more refractory to treatment, and vardenafil's performance in this population is one reason it remains a go-to option for endocrinologists managing sexual health in metabolic disease.
The European Urology Guidelines on male sexual dysfunction recommend all four PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) as first-line therapy. They do not rank one above another for general efficacy, noting that individual response and preference should guide selection. This matches what forums suggest: no single PDE5 inhibitor "wins" across the board. Different bodies respond differently.
What Reddit Users Report About Vardenafil
Online forums provide a window into how vardenafil performs outside the controlled environment of a clinical trial. The usual caveats apply: self-selected respondents, recall bias, no placebo control. Still, the pattern of reports is remarkably consistent with trial outcomes.
On r/Trt, users taking testosterone replacement therapy often discuss PDE5 inhibitors as adjuncts. A recurring observation is that vardenafil produces a "harder" erection than sildenafil at equivalent doses. One frequently cited reason is that vardenafil has a higher binding affinity for PDE5 relative to PDE6, which may explain why some users perceive fewer visual disturbances (the blue tint associated with sildenafil). "Levitra hits faster than Viagra for me and I don't get the stuffy nose as bad," wrote one user on r/Trt in a 2024 thread comparing the three major PDE5 inhibitors.
On r/erectiledysfunction, vardenafil threads tend to come from two groups: men who tried sildenafil first and switched, and men whose physicians started them on vardenafil due to a specific concern (diabetes, for example). Across dozens of threads, users consistently report:
- Onset within 15 to 25 minutes on an empty stomach
- Duration of approximately 4 to 5 hours, shorter than tadalafil but comparable to sildenafil
- Mild headache as the most common side effect, usually subsiding after the first few uses
- Nasal congestion that some describe as "annoying but not a dealbreaker"
- Less flushing compared to sildenafil, according to about a third of users who have tried both
The sample sizes here are small. A typical Reddit thread draws 10 to 40 responses. Selection bias runs strong: men who had terrible experiences or no results are disproportionately motivated to post. So are men who had excellent results. The middle-of-the-road experience is underrepresented. Keep that in mind when reading any user-generated review.
Drugs.com and Structured Review Platforms
Drugs.com collects structured reviews where users rate effectiveness, ease of use, and satisfaction on a 10-point scale. As of early 2026, vardenafil for erectile dysfunction holds an average rating of approximately 8.2 out of 10 across more than 100 reviews, placing it slightly above sildenafil (7.9) and slightly below tadalafil (8.4) on the same platform.
The most common praise in written reviews centers on reliability. Users describe vardenafil as "consistent" and "predictable." Several reviews note that it works even when mild anxiety is present, a real-world variable that clinical trials attempt to exclude. "I was nervous the first time, didn't think anything would work. Took 10 mg of Levitra and within 20 minutes I knew it was working. The confidence boost alone was worth it," wrote one verified purchaser.
Negative reviews cluster around two themes. Cost is the first. Before generic availability, brand Levitra could exceed $50 per pill. Generic vardenafil has reduced that considerably, but the perception of high cost persists. The second theme is duration: men who want a 24- to 36-hour window consistently prefer tadalafil over vardenafil. This is not a failure of vardenafil. It is a pharmacokinetic difference. Vardenafil has a terminal half-life of approximately 4 to 5 hours, compared to tadalafil's 17.5 hours.
A 2019 meta-analysis in the Journal of Sexual Medicine compared patient preference across PDE5 inhibitors. The pooled data showed no statistically significant difference in overall satisfaction between vardenafil and sildenafil. Tadalafil edged both on the "convenience" dimension, largely because of its longer duration. Efficacy ratings were comparable across all three drugs.
How Vardenafil Performs in Specific Populations
The men most likely to seek out vardenafil reviews are often those with complicating factors: diabetes, cardiovascular disease, performance anxiety, or prior failure with another PDE5 inhibitor. The evidence across these subgroups is worth examining individually.
Diabetic ED. The Goldstein et al. (2003) trial in men with type 2 diabetes showed that 72% of intercourse attempts succeeded at the 20 mg dose versus 28% on placebo. Forum users with diabetes confirm this general pattern but note that dose optimization matters. "Started at 10 mg, didn't do much. Went to 20 mg and it was a completely different experience," posted a user on r/diabetes_t2.
Post-prostatectomy ED. A randomized trial in patients after bilateral nerve-sparing radical prostatectomy found that vardenafil 20 mg improved IIEF erectile function scores by 7 points over placebo. Response rates are lower than in the general ED population, which tracks with the degree of nerve damage. Forum users in this subgroup tend to use vardenafil as part of a penile rehabilitation protocol alongside vacuum devices or low-dose daily PDE5 inhibitor therapy.
Performance anxiety overlap. This is harder to study formally but comes up repeatedly in Reddit threads. Men describe a positive feedback loop: vardenafil reliably produces an erection, which reduces anxiety about the next encounter, which eventually reduces dependence on the medication. No controlled trial has isolated this psychological reinforcement, but the American Urological Association guidelines acknowledge that PDE5 inhibitors can serve as a "bridge" while cognitive-behavioral techniques address the anxiety component.
Men on antihypertensives. Vardenafil can interact with alpha-blockers and nitrates. The FDA prescribing information warns against combining vardenafil with nitrates in any form. Users on blood pressure medications should titrate from 5 mg under medical supervision. Several forum users report successful use alongside ACE inhibitors and ARBs without significant blood pressure drops, though individual monitoring remains necessary.
Levitra vs. Staxyn: Does Formulation Matter?
Staxyn is the orally disintegrating tablet (ODT) form of vardenafil, available only in 10 mg. It dissolves on the tongue without water. The pharmacokinetic profile differs slightly from standard Levitra: Staxyn reaches peak plasma concentration about 15 minutes earlier, which some users interpret as a faster onset.
User reviews of Staxyn tend to highlight convenience. "No fumbling with a glass of water, no one even knows you took anything," described one Drugs.com reviewer. The downside: Staxyn is not available as a generic in the U.S., and 10 mg is the only dose option. Men who need 20 mg cannot simply double up on Staxyn, as the ODT bioavailability is not equivalent to two standard 10 mg tablets.
From a practical standpoint, most men filling generic prescriptions will receive standard vardenafil tablets. Staxyn occupies a niche for those who specifically want the discretion and speed of an ODT formulation and are willing to pay the brand premium.
Side Effects: What Users Actually Experience
Clinical trials report side effect rates with precision. The integrated safety analysis of vardenafil across multiple key trials (N=2,203 on vardenafil, 750 on placebo) found headache in 15% of men at 20 mg (vs. 4% placebo), flushing in 11% (vs. 1%), rhinitis in 9% (vs. 3%), and dyspepsia in 4% (vs. 1%). Discontinuation due to side effects was 3.4%.
The numbers mostly match user reports, with two nuances. First, headache tends to diminish with repeated use. Several Reddit users describe the first two or three doses causing noticeable headache, then the symptom fading. This is consistent with physiologic tolerance to vasodilation. Second, users rarely mention the QTc prolongation risk that appears in the prescribing information. This is a dose-dependent effect relevant primarily at supratherapeutic doses or in patients with congenital long QT syndrome. It is not something users typically perceive.
Dr. Irwin Goldstein, director of San Diego Sexual Medicine, has noted in published commentary that "the therapeutic window for PDE5 inhibitors is wide, and most side effects are extensions of the pharmacologic mechanism rather than off-target toxicity." This assessment aligns with the real-world signal: side effects exist but are tolerable for the majority.
How to Interpret Online Reviews Without Being Misled
Every PDE5 inhibitor subreddit and review page contains outlier reports. One user claims vardenafil "changed his life." Another says it "did absolutely nothing." Neither extreme represents the average experience, and several specific biases shape online drug reviews.
Survivorship bias. Men who fill a prescription, use it successfully, and move on with their lives rarely post reviews. The review population skews toward strong reactions, both positive and negative.
Dose confusion. Forum users sometimes report failure at 5 mg without having tried 10 or 20 mg. The Porst trial showed a clear dose-response curve, with success rates climbing from 65% at 5 mg to 80% at 20 mg. A man who "failed" vardenafil at 5 mg may simply need dose escalation.
Timing errors. Taking vardenafil immediately after a large, fatty meal can delay absorption by 60 minutes or more. Users who report slow onset often mention eating beforehand when pressed for details. An empty stomach or a light meal is the standard recommendation.
Counterfeit medications. The WHO estimates that up to 10% of medicines in low- and middle-income countries are substandard or falsified. Users purchasing PDE5 inhibitors from unregulated online pharmacies may receive underdosed or inactive tablets. This is not a vardenafil problem. It is a supply chain problem. Filling prescriptions through licensed pharmacies eliminates this variable.
Practical Recommendations Based on Combined Evidence
The clinical and real-world data converge on a set of concrete recommendations for men considering vardenafil.
Start at 10 mg on an empty stomach, 30 to 60 minutes before anticipated sexual activity. This is the FDA-recommended starting dose and the dose that most forum users describe as their baseline. If 10 mg provides an adequate response, stay there. If response is partial, titrate to 20 mg after consulting with a prescriber.
Do not combine vardenafil with nitrates. This is not a guideline nuance or an academic concern. Concurrent use produces unpredictable hypotension that can be life-threatening. The FDA label is unambiguous on this point.
If vardenafil works well for spontaneous encounters but you want a longer action window, discuss tadalafil 5 mg daily with your provider. Many forum users describe rotating between vardenafil for planned encounters and daily tadalafil for spontaneity. The AUA/SMSNA guidelines support PDE5 inhibitor switching when the first agent is partially effective or poorly tolerated.
Expect mild side effects for the first two to three uses. If headache persists beyond the first week of use, taking 200 mg ibuprofen 30 minutes before vardenafil is a common patient-reported strategy, though it lacks formal trial evidence.
Track your response. The IIEF-5 questionnaire takes two minutes and gives you and your provider an objective measure of whether the medication is working. A score improvement of 4 or more points from baseline is considered clinically significant per Rosen et al. (1997).
Frequently asked questions
›Does vardenafil (Levitra/Staxyn) actually work?
›What do people say about vardenafil (Levitra/Staxyn)?
›How fast does vardenafil start working?
›How long does vardenafil last?
›Is vardenafil better than sildenafil (Viagra)?
›Can I take vardenafil with blood pressure medication?
›What are the most common side effects of vardenafil?
›Does vardenafil work for diabetic ED?
›Is generic vardenafil as effective as brand Levitra?
›Why did vardenafil not work for me?
›Can I take vardenafil every day?
›How does Staxyn differ from Levitra?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199.
- Goldstein I, Young JM, Fischer J, et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care. 2003;26(3):777-783.
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of vardenafil in men with erectile dysfunction following radical prostatectomy. J Urol. 2003;170(4 Pt 1):1278-1283.
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health. Eur Urol. 2022;82(1):49-64.
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641.
- Klotz T, Sachse R, Heidrich A, et al. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World J Urol. 2001;19(1):32-39.
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912.
- Rajagopalan P, Mazzu A, Lipari J, et al. Vardenafil orodispersible tablet pharmacokinetics. J Sex Med. 2010;7(5):1788-1796.
- Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between vardenafil and nitrates. J Am Coll Cardiol. 2003;42(12):2128-2134.
- FDA. Levitra (vardenafil) prescribing information. Revised 2014.
- World Health Organization. Substandard and falsified medical products fact sheet. WHO, 2018.
- Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830.